Determination of IGFs and their binding proteins

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 27, Issue 6, 2013, Pages 771-781

  Hjortebjerg, Rikke ^a   Frystyk, Jan ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

assay development; consensus statement; IGF I; IGFBP; immunoassay; post analytical; pre analytical

Indexed keywords

BINDING PROTEIN; SOMATOMEDIN;

ARTICLE; CHEMOLUMINESCENCE; CONSENSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEOMICS; RADIOIMMUNOASSAY; TIME RESOLVED IMMUNOFLUOROMETRIC ASSAY;

ASSAY DEVELOPMENT; CONSENSUS STATEMENT; IGF-I; IGFBP; IMMUNOASSAY; POST-ANALYTICAL; PRE-ANALYTICAL;

HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II;

EID: 84888318766     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2013.08.010     Document Type: Review

References (95)

1. D.R. Clemmons Value of insulin-like growth factor system markers in the assessment of growth hormone status Endocrinol Metab Clin North Am 36 2007 109 129 (Pubitemid 46335846)
2. D.R. Clemmons Consensus statement on the standardization and evaluation of growth hormone and insulin like growth factor assays Clin Chem 57 2011 555 559
3. Y. Zhang, X. Ying, and S. Han Autoantibodies against insulin-like growth factor-binding protein 2 as a serological biomarker in the diagnosis of lung cancer Int J Oncol 42 2013 93 100
4. U. Petersson, C.J. Ostgren, and L. Brudin Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Soderakra Cardiovascular Risk Factor Study Diabetes Metab 35 2009 198 205
5. A.B. Postnikov, T.I. Smolyanova, and A.V. Kharitonov N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia Clin Biochem 45 2012 519 524
6. H.P. Guler, J. Zapf, and C. Schmid Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates Acta Endocrinol (Copenh) 121 1989 753 758 (Pubitemid 20029527)
7. J. Frystyk, M. Hussain, and C. Skjærbæk The pharmacokinetics of free insulin-like growth factor-I in healthy subjects Growth Horm IGF Res 9 1999 150 156 (Pubitemid 29320372)
8. J. Frystyk Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis Growth Horm IGF Res 14 2004 337 375 (Pubitemid 39185988)
9. J.I. Jones, and D.R. Clemmons Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 1995 3 34
10. C.A. Conover Key questions and answers about pregnancy-associated plasma protein-A Trends Endocrinol Metab 23 2012 242 249
11. J. Frystyk Quantification of the GH/IGF-axis components: lessons from human studies Domest Anim Endocrinol 43 2012 186 197
12. S.M. Firth, and R.C. Baxter Cellular actions of the insulin-like growth factor binding proteins Endocr Rev 23 2002 824 854 (Pubitemid 35454590)
13. D.R. Clemmons Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes Endocr Metab Clin North Am 41 2012 425 443
14. S. Yakar, and M.L. Adamo Insulin-like growth factor 1 physiology: lessons from mouse models Endocrinol Metab Clin North Am 41 2012 231 247
15. F. Frasca, G. Pandini, and L. Sciacca The role of insulin receptors and IGF-I receptors in cancer and other diseases Arch Physiol Biochem 114 2008 23 37 (Pubitemid 351998752)
16. M.M. Chitnis, J.S. Yuen, and A.S. Protheroe The type 1 insulin-like growth factor receptor pathway Clin Cancer Res 14 2008 6364 6370
17. A.A. Samani, S. Yakar, and D. LeRoith The role of the IGF system in cancer growth and metastasis: overview and recent insights Endocr Rev 28 2007 20 47 (Pubitemid 46220849)
18. L.K. Harris, and M. Westwood Biology and significance of signalling pathways activated by IGF-II Growth Factors 30 2012 1 12
19. J. Brown, E.Y. Jones, and B.E. Forbes Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure Trends Biochem Sci 34 2009 612 619
20. D. Bergman, M. Halje, and M. Nordin Insulin-like growth factor 2 in development and disease: a mini-review Gerontology 59 2013 240 249
21. C. Hawkes, and S. Kar The insulin-like growth factor-II/mannose-6- phosphate receptor: structure, distribution and function in the central nervous system Brain Res Rev 44 2004 117 140 (Pubitemid 38293429)
22. M. Halje, M. Nordin, and D. Bergman Review: the effect of insulin-like growth factor II in the regulation of tumour cell growth in vitro and tumourigenesis in vivo In Vivo 26 2012 519 526
23. A.M. Fernandez, and I. Torres-Alemán The many faces of insulin-like peptide signalling in the brain Nat Rev Neurosci 13 2012 225 239
24. W.F. Blum, K. Albertsson-Wikland, and S. Rosberg Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion J Clin Endocrinol Metab 76 1993 1610 1616 (Pubitemid 23164387)
25. A.T. Reutens, D.M. Hoffman, and K.C. Leung Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency J Clin Endocrinol Metab 80 1995 480 485
26. A.L. Barkan, I.Z. Beitins, and R.P. Kelch Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion J Clin Endocrinol Metab 67 1988 69 73
27. M.E. Molitch, D.R. Clemmons, and S. Malozowski Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 96 2011 1587 1609
28. L. Katznelson, J.L. Atkinson, and D.M. Cook American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update Endocr Pract 17 Suppl. 4 2011 1 44
29. A. Giustina, and J.D. Veldhuis Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human Endocr Rev 19 1998 717 797 (Pubitemid 128506521)
30. M.L. Hartman, P.E. Clayton, and M.L. Johnson A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans J Clin Invest 91 1993 2453 2462 (Pubitemid 23182496)
31. K.C. Leung, N. Doyle, and M. Ballesteros Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation J Clin Endocrinol Metab 85 2000 4712 4720 (Pubitemid 32157657)
32. H.K. Gleeson, C.A. Lissett, and S.M. Shalet Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity J Clin Endocrinol Metab 90 2005 1061 1067 (Pubitemid 40279234)
33. J. Frystyk, R.A. Ritzel, and J. Maubach Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis Clin Endocrinol Metab 93 2008 1758 1766 (Pubitemid 351656515)
34. A. Juul Serum levels of insulin-like growth factor I and its binding proteins in health and disease Growth Horm IGF Res 13 2003 113 170 (Pubitemid 36986557)
35. S.B. Wheatcroft, and M.T. Kearney IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis Trends Endocrinol Metab 20 2009 153 162
36. K. Hedbacker, K. Birsoy, and R.W. Wysocki Antidiabetic effects of IGFBP2, a leptin-regulated gene Cell Metab 11 2010 11 22
37. R. Mehrian-Shai, C.D. Chen, and T. Shi Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer Proc Natl Acad Sci U S A 104 2007 5563 5568 (Pubitemid 47175720)
38. S. Mazerbourg, I. Callebaut, and J. Zapf Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo Growth Horm IGF Res 14 2004 71 84 (Pubitemid 38332072)
39. R. Durai, M. Davies, and W. Yang Biology of insulin-like growth factor binding protein-4 and its role in cancer (review) Int J Oncol 28 2006 1317 1325
40. M. Akkiprik, Y. Feng, and H. Wang Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer Breast Cancer Res 10 2008 212
41. J. Beattie, G.J. Allan, and J.D. Lochrie Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis Biochem J 395 2006 1 19
42. L.A. Bach, P. Fu, and Z. Yang Insulin-like growth factor-binding protein-6 and cancer Clin Sci (London) 124 2013 215 229
43. W.H. Daughaday, and P. Rotwein Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations Endocr Rev 10 1989 68 91 (Pubitemid 19156368)
44. S. Rajaram, D.J. Baylink, and S. Mohan Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions Endocr Rev 18 1997 801 831 (Pubitemid 28009568)
45. L.A. Bach, S.J. Headey, and R.S. Norton IGF-binding proteins - the pieces are falling into place Trends Endocrinol Metab 16 2005 228 234 (Pubitemid 40853886)
46. D.R. Clemmons Use of mutagenesis to probe IGF-binding protein structure/function relationships Endocr Rev 22 2001 800 817 (Pubitemid 34214296)
47. J.I. Jones, A.J. D'Ercole, and C. Camacho Hubner Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I Proc Natl Acad Sci U S A 88 1991 7481 7485 (Pubitemid 21915176)
48. J.I. Jones, A. Gockerman, and W.H. Busby Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I J Cell Biol 121 1993 679 687
49. G. Lippi, K. Becan-McBride, and D. Behulova Preanalytical quality improvement: in quality we trust Clin Chem Lab Med 51 2013 229 241
50. R. Hawkins Managing the pre- and post-analytical phases of the total testing process Ann Lab Med 32 2012 5 16
51. J. Frystyk, P. Freda, and D.R. Clemmons The current status of IGF-I assays - a 2009 update Growth Horm IGF Res 20 2010 8 18
52. H. Yu, J. Mistry, and M.J. Nicar Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation J Clin Lab Anal 13 1999 166 172 (Pubitemid 29309773)
53. D.P. Belobrajdic, I.K. Priebe, and B. Forbes Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk Growth Horm IGF Res 18 2008 198 204 (Pubitemid 351479924)
54. A.M. Arafat, M.O. Weickert, and J. Frystyk The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity J Clin Endocrinol Metab 94 2009 5093 5103
55. S.I. Yeoh, and R.C. Baxter Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma Acta Endocrinol (Copenh) 119 1988 465 473 (Pubitemid 19012445)
56. J. Van Doorn, A.J. Cornelissen, and S.C. Buul-Offers Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions Clin Endocrinol (Oxford) 54 2001 655 664 (Pubitemid 34208910)
57. C. Massart, and J.Y. Poirier Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays Clin Chim Acta 373 2006 176 179 (Pubitemid 44292191)
58. J.L. Van den Brande A personal view on the early history of the insulin-like growth factors Horm Res 51 1999 149 175
59. R.W. Furlanetto, L.E. Underwood, and J.J. Van Wyk Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay J Clin Invest 60 1977 648 657 (Pubitemid 8180868)
60. J. Frystyk, B. Dinesen, and H. ∅rskov Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II Growth Regu 5 1995 169 176 (Pubitemid 26018330)
61. W.E. Sonntag, A. Csiszar, and R. de Cabo Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies J Gerontol Ser A Biol Sci Med Sci 67A 2012 587 598
62. M. Pollak The insulin and insulin-like growth factor receptor family in neoplasia: an update Nat Rev Cancer 12 2012 159 169
63. D.E. Berryman, J.S. Christiansen, and G. Johannsson Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models Growth Horm IGF Res 18 2008 455 471
64. Torres-Alemán Insulin-like growth factor-1 and central neurodegenerative diseases Endocrinol Metab Clin North Am 41 2012 395 408
65. C. Burns, P. Rigsby, and M. Moore The first international standard for insulin-like growth factor-I (IGF-I) for immunoassay: preparation and calibration in an international collaborative study Growth Horm IGF Res 19 2009 457 462
66. A. Krebs, H. Wallaschofski, and E. Spilcke-Liss Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population Clin Chem Lab Med 46 2008 1776 1783
67. J. Argente, N. Caballo, and V. Barrios Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation J Clin Endocrinol Metab 82 1997 2084 2092 (Pubitemid 27287565)
68. J. Frystyk, C. Skjærbæk, and E. Vestbo Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes Diabetes/Metab Res Rev 15 1999 314 322 (Pubitemid 29535090)
69. P.M. Jehle, A. Ostertag, and K. Schulten Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy Kidney Int 57 2000 423 436 (Pubitemid 30430634)
70. J. Frystyk, P. Ivarsen, and C. Skjærbæk Serum free insulin-like growth factor I correlates with clearance in patients with chronic renal failure Kidney Int 56 1999 2076 2084 (Pubitemid 30004736)
71. N. Jeyaratnaganthan, H. Grønbæk, and P. Holland-Fischer Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum Clin Endocrinol (Oxford) 72 2010 625 632
72. M.P. Brugts, J.G. Luermans, and E.G. Lentjes Heterophilic antibodies may be a cause of falsely low total IGF1 levels Eur J Endocrinol 161 2009 561 565
73. A.G. Marks, J.M. Carroll, and J.Q. Purnell Plasma distribution and signaling activities of IGF-II precursors Endocrinology 152 2011 922 930
74. U. Espelund, J.M. Bruun, and B. Richelsen Pro- and mature IGF-II during diet-induced weight loss in obese subjects Eur J Endocrinol 153 2005 861 869 (Pubitemid 43020237)
75. P. Hossenlopp, D. Seurin, and B. Segovia-Quinson Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies Anal Biochem 154 1986 138 143 (Pubitemid 16063354)
76. S.E. Gargosky, H.M. Pham, and K.F. Wilson Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting Endocrinology 131 1992 3051 3060
77. C. Skjærbæk, J. Frystyk, and H. ∅rskov Free IGF-I, IGFBP-1, and the binary complex of IGFBP-1 and IGF-I are increased during human pregnancy Horm Res 62 2004 215 220 (Pubitemid 39551734)
78. C. Skjærbæk, J. Frystyk, and H. ∅rskov Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis J Clin Endocrinol Metab 83 1998 2445 2449 (Pubitemid 28503045)
79. A.M. Suikkari, and R.C. Baxter Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum J Clin Endocrinol Metab 74 1992 177 183
80. M. Langkamp, K. Weber, and M. Kirschner Validation of functional insulin-like growth factor binding protein-3 measurement by a ligand immunoassay Clin Lab 56 2010 535 542
81. H. Koistinen, A. Paju, and R. Koistinen Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3 Prostate 50 2002 112 118 (Pubitemid 34123700)
82. H. Koistinen, M. Seppala, and R. Koistinen Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies Clin Chem 40 1994 531 536 (Pubitemid 24116098)
83. J. Frystyk, C.B. Djurhuus, and T. Johansen Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days Nephrol Dial Transplant 27 2012 4211 4218
84. P. Ivarsen, J.W. Chen, and I. Tietze Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis Growth Horm IGF Res 20 2010 156 161
85. M. Westwood, J.M. Gibson, and A.C. Williams Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status J Clin Endocrinol Metab 80 1995 3520 3527
86. J. Frystyk, K. Højlund, and K.N. Rasmussen Development and clinical evaluation of a novel immunoassay for the binary complex of insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 in human serum J Clin Endocrinol Metab 87 2002 260 266 (Pubitemid 34084700)
87. P. Marzullo, C. Di Somma, and K.L. Pratt Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults J Clin Endocrinol Metab 86 2001 3001 3008 (Pubitemid 32673456)
88. J.W. Chen, T. Ledet, and H. ∅rskov A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum Am J Physiol - Endocrinol Metab 284 2003 E1149 E1155
89. M.D. Sadick, A. Intintoli, and V. Quarmby Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays J Pharm Biomed Anal 19 1999 883 891 (Pubitemid 29127202)
90. U. Espelund, K. Søndergaard, and P. Bjerring Interstitial fluid contains higher in vitro IGF bioactivity than serum: a study utilizing the suction blister technique Growth Horm IGF Res 22 2012 234 239
91. R.W. Nelson, D. Nedelkov, and K.A. Tubbs Quantitative mass spectrometric immunoassay of insulin like growth factor 1 J Proteome Res (ACS Publications) 3 2004 851 855 (Pubitemid 39166247)
92. S. Bobin, M.A. Popot, and Y. Bonnaire Approach to the determination of insulin-like-growth-factor-I (IGF-I) concentration in plasma by high-performance liquid chromatography-ion trap mass spectrometry: use of a deconvolution algorithm for the quantification of multiprotonated molecules in electrospray ionization Analyst 126 2001 1996 2001 (Pubitemid 33097132)
93. R. Kay, D.J. Halsall, and A.K. Annamalai A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly Clin Endocrinol (Oxford) 78 2013 424 430
94. A. Thomas, M. Kohler, and W. Schanzer Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS Analyst 136 2011 1003 1012
95. M. Kohler, A. Thomas, and K. Walpurgis Detection of His-tagged Long-R3-IGF-I in a black market product Growth Horm IGF Res 20 2010 386 390